New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared to ...

WENZHOU, ZHEJIANG, CHINA, January 5, 2026 /EINPresswire.com/ — In the world of electrical engineering, automation, and power management, the relay is the quiet workhorse. It’s the component ...

Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

Innocan Pharma Corporation (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, today announced that it anticipates ...

Helping engineering teams overcome integration, durability, and safety hurdles in harsh environments By Paulius Juskevicius, ...

President Donald Trump has locked in a sweeping set of pricing agreements with nine of the world's biggest drugmakers, promising to pull some of the most expensive medicines on the U.S. market closer ...

Grocers can capitalize on innovation in frozen seafood as health-conscious consumers look to increase their consumption ...

Two years after arriving from Puerto Rico, the junior guard and fellow captains Robert Liriano-Alejandro and Ty Pindel have ...

Amgen AMGN recently signed a landmark agreement with the Trump administration to lower drug prices in the United States.

Amgen and eight other pharma giants struck deals with the Trump administration to cut U.S. drug prices while gaining tariff relief and manufacturing incentives.